An estimated third of rheumatologists send aspirated synovial¯uid samples for culture routinely during the course of management of their patients irrespective of the underlying diagnosis. This is done apparently even when sepsis is not suspected. This audit of 507 synovial¯uid culture requests revealed that positive bacterial growth was rare even when sepsis was queried on the request forms but none was positive in any of the routine samples. Our ®ndings throw doubt on the value of routine synovial¯uid culture. We recommend that such cultures are undertaken when infection is a possibility and in immuno-compromised patients. An average health district would save £3000 per annum if such a policy was adopted, but across the National Health Service as a whole the total expenditure saved on this unnecessary investigation would be considerable.
SYNOVIAL¯uid analysis for cell counts and crystals is one of the most useful investigations in rheumatological disorders when the diagnosis is uncertain [1] . Similarly, synovial¯uid culture is essential in suspected cases of septic arthritis or when aspirated¯uid looks suspicious or unduly turbid [2] . In practice, it seems that a large number of aspirated synovial¯uid samples are routinely sent for culture despite no suspicion of sepsis. We base this statement on a questionnaire study [3] asking rheumatologists their routine practice regarding this aspect: 22% stated that they did send all aspirated synovial¯uids for culture as a routine matter even if sepsis was not in question. This also seemed to be our local practiceÐ where routinely all aspirated¯uids are sent for culture. Furthermore, when we presented this paper as an abstract at the recent British Society for Rheumatology meeting in London [4] , the chairman asked for a show of hands of those who sent samples for culture just as a routine practice. Of the estimated 400 rheumatologists attending at the time, an estimated minimum of one-third indicated that they did so. As such, throughout the NHS it is likely that a huge number of synovial¯uids are apparently cultured even when sepsis is not suspected.
We audited requests in two districts to assess the value of routine synovial¯uid culture.
PATIENTS AND METHODS
Sample requests (n = 99) for synovial¯uid culture from South Manchester University Hospitals NHS Trust (SMUHT) for three consecutive months were analysed, the sources of referral being as follows: rheumatology 25, orthopaedics 11, accident and emergency 17, medical disciplines 10, miscellaneous 36. Similarly, 408 requests to Stockport district hospitals in 1 yr were analysed. The sources of referral were as follows: the majority, i.e. 225 samples (55%), were from the rheumatology department, including from`cold' elective admission beds and out-patients; 66 samples (16%) were from orthopaedic wards or patients admitted from accident and emergency or out-patient departments; 24 samples (6%) were from general medical out-patients; and 29 (7%) were from general medical wards and miscellaneous group. General practitioner (GP) originated samples amounted to 64.
RESULTS
Analysis of SMUHT samples revealed that details (e.g. age or sex of patient, source/site of aspirated synovial¯uid, underlying diagnosis or information as to whether sepsis was suspected or not) were lacking in 54 request forms, six of which were positive for Staphylococcus aureus (St ar), i.e. >11% of the samples; infection was queried in 12 samples, of which three were positive, i.e. 25% (two St ar and one Streptococcus); joint eusion was mentioned on 11 request forms, of which one was positive for Clostridium perfringens from enrichment culture only (?signi®cance); clinical details were illegible in 19 samples, of which all were negative for growth; two samples were from patients with carcinoma of the lung, of which one was positive for St ar, and in one patient cellulitis was the diagnosis and the¯uid from this patient was positive for St ar. From the patient details available on the request forms, a random 33 patients' records were analysed for further details. The age range was 12±94 yr with 23 male and 10 female patients. Their diagnoses included rheumatoid arthritis (RA) (4), oesteoarthritis (OA) (9), bursitis (4), injury (5), ?sepsis (3), ?gout (2) and miscellaneous (6). No entry was recorded in the notes of the fact that the synovial¯uid was sent for culture in 19 cases (in the rest this was so recorded). In the discharge summaries to the GP, no information relating to synovial¯uid culture was included in 18 of the patients. Stockport samples were as follows: female 220 (54%), male 187 (46%). On one sample the gender was not stated. The majority (344) of the samples were from hospitals (84.3%) and 64 samples came from GP practice (15.7%). From rheumatology department and elective admission patients, the diagnoses discernible included RA (n = 98) and a smaller number were OA patients (n = 14). In only 24 samples was sepsis actually queried on the request forms. In the remainder, it was not possible to get any diagnosis from the request forms. The number with bacterial growth was 19 (4.7%), of which 12 were St ar, six coagulase-negative Staphylococcus and one anaerobic cocci. The bacterial growth samples came from either general medical wards or casualty and there was not a single bacterial growth from samples sent from cold/elective admission beds. From the patients' details given on the request forms, a random 52 case notes (from rheumatology and orthopaedic departments mainly, but none from GP sources) from Stockport district were analysed. Of these, 36 were female and 16 male, the age range being 24±94 yr. As expected, the majority were patients with RA (n = 29) and a smaller number were OA patients (n = 8), the rest being miscellaneous; it was notable that sepsis was not actually queried on the request forms, not even in a single patient. From case notes studied, no reasons were mentioned for sending synovial¯uid for culture in 51 cases and turbidity was noted in six samples. No entry was made in the notes nor mention made in the discharge summary to the GP regarding this information on culture and sensitivity. In general, there was poor quality of accompanying information on request forms for synovial¯uid culture samples. On this basis, it would have been dicult to reject or discriminate in any way for low-risk samples. There was overall 10% positivity for growth from SMUHT, but under 5% from Stockport district because of the dilution eect of the major cold admissions in this district for rheumatology and orthopaedic patients. Synovial¯uid from casualty and some orthopaedic samples was more often positive than that from elective admission beds and the GPs' samples yielded only a few positives.
In none of the case records that we have been able to scrutinize did we ®nd that injection with corticosteroid was withheld when synovial¯uid samples were routinely sent for culture.
COMMENTS
In rheumatological practice, it is customary to perform synovial¯uid analysis, where sample is available, to aid diagnosis [1] . Synovial¯uid culture is undeniably of the utmost importance where sepsis is clinically suspected or needs to be excluded in certain complicated clinical situations, e.g. in immunocompromised patients [2] . The value of routine synovial¯uid culture is, however, doubtful when treating patients with an already established diagnosis such as RA, OA or even one of the connective tissue disorders provided, on individual patient's assessment, sepsis is not a possibility. A large proportion of the known rheumatoid patients admitted for routine management, e.g. joint aspiration and steroid injection, have a stable clinical condition with no apparent possibility of sepsis of the joints in question. It is in these patients that routine synovial¯uid culture would appear to be unnecessary. However, any synovial¯uid samples looking unduly turbid and samples from immunocompromised patients should be cultured. Non-in¯ammatory¯uids, e.g. from OA patients, do not require this extra precaution.
From our estimation, perhaps a third of rheumatologists routinely send all aspirated synovial¯uids for culture even when sepsis is not in question. Most of these practitioners apparently do not wait for the culture report to appear before injecting joints with steroids. Thus, there seems to be no logic in sending synovial¯uid for culture unless, of course, sepsis is suspected.
Our audit ®ndings indicate that routine culturing of aspirated synovial¯uids may be unnecessary, especially when treating patients in cold/elective admission beds. A more cost-eective way of using limited resources may be culturing¯uids when there is a clinical indication, in immunocompromised patients, or in doubtful cases.
As synovial¯uid culture costs around £7.50 per sample, this could mean an average cost saving for a district of H£3000. Thus, the saving in the NHS as a whole could be considerable.
